DF/HCC offers a multitude of funding opportunities to its members to encourage and enhance the collaborative spirit of research within the Harvard medical community

The NIH continues to recognize DF/HCC as a leader in cancer research by awarding funding to a number of our research initiatives

Dana-Farber/Harvard Cancer Center and the University of Massachusetts Boston have been awarded $11 million over the next five years by the NCI to embolden their strong collaborative cancer research, training, and outreach program

A number of DF/HCC members have received top honors, awards, and distinctions since we published eNews last

The High-Throughput Polymorphism Detection Core (HTPC) provides services to DF/HCC investigators conducting molecular analyses of germline DNA collected as part of a wide range of investigations into the molecular epidemiology of cancer, including Genome Wide Association Studies (GWAS)

Forty-five individuals have recently joined DF/HCC

Pancreatic cancer has literally walled itself off for decades from efforts to find an effective drug therapy